Antimicrobial coating for inhibition of bacterial adhesion and biofilm formation

Abstract

The present invention provides antimicrobial coatings for coating substrate surfaces, particularly medical devices, for preventing bacterial adhesion and biofilm formation by inhibiting microbial growth and proliferation on the coating surface. The antimicrobial coatings are composed of a hydrogel and a bioactive agent including a substantially water-insoluble antimicrobial metallic material that is solubilized within the coating. Antimicrobial coating formulations for obtaining such coatings, and coating methods are also described.

Description

RELATED APPLICATION[0001]This application claims the benefit of U.S. Provisional Application No. 60 / 566,576, filed on Apr. 29, 2004. The entire teachings of the above application is incorporated herein by reference.FIELD OF THE INVENTION[0002]The present invention relates to an antimicrobial coating for coating a substrate surface, particularly medical devices that are likely to become contaminated or have become contaminated with microorganisms as a result of bacterial adhesion and proliferation and methods for preventing biofilm formation by inhibiting microbial growth and proliferation on the surface of medical devices.BACKGROUND OF THE INVENTION[0003]Colonization of bacteria on the surfaces of medical devices and healthcare products, particularly in implanted devices, result in serious patient problems, including the need to remove and / or replace the implanted device and to vigorously treat secondary infection conditions. Considerable efforts, therefore, have been directed towar...

AI Technical Summary

Benefits of technology

[0010]The present invention is based upon the realization that a substantially water-insoluble antimicrobial material can be incorporated into a hydrophilic polymeric coating in a substantially “solubilized’ form wherein the water insoluble antimicrobial material is dispersed homogeneously in a three dimensional hydrogel network gel, formed by a hydrophilic polymer in a substantially homogenous manner, thereby enabling incorporation of high concentrations of a bacteriostatic or bactericidal material in relatively thin coatings, and resulting in increased coating antimicrobial efficacy for extended periods. The coatings of the invention, therefore, inhibit bacterial adhesion and biofilm formation on coated surfaces such as medical devices and healthcare products.

[0011]The present invention concerns an antimicrobial coating comprising a cross-linked polymeric material comprising a biologically active or “bioactive” agent and at least one substantially water-insoluble antimicrobial metallic compound maintained in a substantially “solubilized” form within the coating that inhibits bacterial adhesion and proliferation on the coating surface, thereby inhibiting the formation of biofilm. It has been surprisingly found that maintaining the water-insoluble antimicrobial metallic compound in a solubilized form within the hydrogel coating imparts substantially high coating antimicrobial efficacy that is maintained over an extended duration of time relative to hydrogel coatings within which the water-insoluble antimicrobial metallic compound is dispersed as micronized heterogeneous particles.

[0013]In another aspect, the present invention provides an antimicrobial coating wherein substantially water-insoluble, poorly ionizing (weakly active) silver compounds or silver complexes are rendered more active in a sustained manner over a longer duration of time by maintaining them in a homogeneously dispersed, solubilized form within the coating.

[0014]In a further aspect, the present invention provides a coating formulation comprising a hydrophilic polymeric material and a substantially water-insoluble metallic antimicrobial compound that is dispersed in a substantially homogenous phase in the coating formulation complex structure rendering silver ions stable against loss of the antiseptic activity and against darkening due to reduction of the silver ions or the formation of darkly stained sparingly or insoluble silver compounds.

Problems solved by technology

Colonization of bacteria on the surfaces of medical devices and healthcare products, particularly in implanted devices, result in serious patient problems, including the need to remove and / or replace the implanted device and to vigorously treat secondary infection conditions.

Formation of biofilms on the surface of medical devices can be detrimental to the integrity of the medical device, present health risks, and prevent sufficient flow through the lumens of medical devices.

Although coating or cleaning medical devices with antimicrobial agents, such as antibiotics or antiseptics, can be effective in killing or inhibiting growth of free-floating or “planktonic” organisms not adhered to the device surface, such antimicrobial agents are generally much less active against the microorganisms that are deeply embedded within the biofilm due to their inability to penetrate the biofilm.

The failure of the antimicrobial agents to sufficiently remove the microorganisms is therefore largely due to the protective effect of the biofilm which prevents diffusion of antimicrobial deep into the biofilm layer to eliminate the microorganisms proliferating within therein.

Biofilm associated problems experienced with implantable medical devices such as catheters, particularly catheters designed for urinary tract infections, pose a significant risk for catheterized patients of acquiring secondary infection such as nosocomial infection in a hospital environment.

Such infections can result in prolonged hospital stay, administration of additional antibiotics, and increased cost of post-operative hospital care.

Although, the use of antimicrobially coated catheters wherein antibiotic agents or antimicrobial compounds are dispersed within the coating have been reported to reduce the incidence of catheter associated bacteriuria, such coatings have proven to be largely ineffective in preventing bacterial adhesion and biofilm formation on the catheter surface for extended periods, and therefore do not sufficiently retard the onset of bacterial infection.

Silver nitrate however, can cause toxic side effects at these concentrations, and does cause discoloration of the skin (Argyria).

Unlike antibiotics, the potential for bacterial to become silver ion resistant is therefore quite low.

However, it is also recognized that silver compounds capable of providing bactericidal levels of silver ion have reduced photostability, and tend to discolor in presence of light and or heat as a result of photoreduction of Ag+ ion to metallic silver.

Furthermore, commonly used terminal sterilization processes such as gamma or e-beam radiation of coatings or formulations containing such silver compounds results in discoloration and loss of activity in such materials, whether it is in the form a cream, gel or as a coating on a medical device.

Silver compounds that have extremely low solubility in aqueous solutions such as silver iodide (Ksp˜10−18) and silver sulfide (Ksp˜10−52) on the other hand, are relatively more photostable but poorly ionized, and hence cannot provide bactericidal levels of silver ions into the contacting environment.

However, they are incorporated as micronized particles suspended within the coating which effectively reduces the effective concentration of Ag+ ions released from such coatings, resulting in shorter coating efficiency and greater tendency to fail in bacterially rich or growth promoting environments.

The substantially low water solubility of AgSD has however, limited its use in antimicrobial coatings, particularly in thin coatings for medical devices.

Attempts to incorporate AgSD into antimicrobial coatings involve dispersion AgSD as micronized particles within relatively hydrophilic polymeric coating materials such as polyethyleneglycol (PEG) and polyvinylalcohol(PVA) which significantly limits the ability to obtain high AgSD concentrations in thin coatings, without compromising coating integrity and mechanical properties.

European patent application EP 83305570 discloses a polyvinylpyrollidone hydrogel containing micronized AgSD and cross-linked by e-beam radiation used as an absorbent wound dressing. . . . Such hydrogel absorbent materials are however, not suitable for coating of medical devices in which high loading of particulate AgSD is not achievable.

Furthermore, the antimicrobial efficacy of such coatings are relatively poor because of the relatively low concentrations of silver (Ag+) ions in the coating, and such coatings therefore require additional water-soluble antimicrobial compounds, such as chlorhexidine to provide bactericidal levels of antimicrobial agents in the contacting environment.

Such increased elution of the non-silver agent however, is likely to adversely affect the duration of coating efficacy, since the coating becomes depleted of the soluble agent in a relatively short period of time.

Such antimicrobial coatings therefore, are not optimal for medical devices that remain implanted in the patient for longer periods of time (several days to weeks).

Images